clopidogrel has been researched along with Cytokine Release Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Anil Kumar, S; Othman, M; Tafazoli, A | 1 |
1 review(s) available for clopidogrel and Cytokine Release Syndrome
Article | Year |
---|---|
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
Topics: Abciximab; Acute Disease; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Fibrinolytic Agents; Humans; Lung; Platelet Activation; Pulmonary Embolism; SARS-CoV-2; Treatment Outcome | 2022 |